ProMIS Neurosciences (@ProMISinc) header
ProMIS Neurosciences (@ProMISinc) profile picture

ProMIS Neurosciences

@ProMISinc

ProMIS is focused on development of antibody therapeutics targeting toxic proteins implicated in Alzheimer’s, ALS and multiple system atrophy. NASDAQ:PMN

 Toronto, Ont. & Cambridge, MA
promisneurosciences.com/
Joined October 2015
  • Tweets757
  • Following366
  • Followers725
147Media
Photo by ProMIS Neurosciences (@ProMISinc)Photo by ProMIS Neurosciences (@ProMISinc)Photo by ProMIS Neurosciences (@ProMISinc)Photo by ProMIS Neurosciences (@ProMISinc)Photo by ProMIS Neurosciences (@ProMISinc)Photo by ProMIS Neurosciences (@ProMISinc)Photo by ProMIS Neurosciences (@ProMISinc)Photo by ProMIS Neurosciences (@ProMISinc)Photo by ProMIS Neurosciences (@ProMISinc)Photo by ProMIS Neurosciences (@ProMISinc)
We are proud to support the Equity in Neuroscience & Alzheimer’s Clinical Trials (ENACT) Act! This bill would increase participation of underrepresented communities in dementia clinical trials. Learn more and take action: p2a.co/xuOMRgm. #ENACTAct #ENDALZ
Image from Alzheimer's Association (@alzassociation)
14
1
26
ProMIS Neurosciences retweeted
Science in Vancouver (@ScienceVancity) profile picture
Science in Vancouver
@ScienceVancity3 Aug 2022
🧠 Dr. Neil Cashman of @DMCBrainHealth and @ProMISinc is leading a team of Canadian neuroscientists working to develop a vaccine against #neurodegenerative diseases caused by the misfolded protein #AlphaSynuclein. Learn more: bit.ly/3OStbRV
Image from Science in Vancouver (@ScienceVancity)
2
7
ProMIS Neurosciences retweeted
Western BrainsCAN (@Brains_CAN) profile picture
Western BrainsCAN@Brains_CAN2 Aug 2022
#WesternU's @maximoprado is part of a team working on a vaccine against neurodegenerative diseases caused by the misfolded protein alpha-synuclein (A-syn). Led by Dr. Neil Cashman from @DMCBrainHealth, the project is supported by @WestonFamilyFdn. centreforbrainhealth.ca/news…
New collaborative research grant will support the development of a vaccine for misfolded protein...

New collaborative research grant will support the development of a vaccine for misfolded protein...

A new grant from the Weston Family Foundation through the Weston Brain Institute will support the research and development of a vaccine against

centreforbrainhealth.ca
5
11
ProMIS Neurosciences retweeted
NeurologyLive® (@neurology_live) profile picture
NeurologyLive®
@neurology_live8 Jul 2020
James Kupiec, chief medical officer of @ProMISinc, recently commented on how the agent will help propel innovation needed to drive the next generation of therapies for #Alzheimers. neurologylive.com/clinical-f…
1
1
5
ProMIS Neurosciences retweeted
Life Sciences Report (@SWLifeSciences) profile picture
Life Sciences Report
@SWLifeSciences6 May 2020
Building a Better Covid-19 Antibody Test: ow.ly/vqJ250zyVWD ProMIS is harnessing its unique technology platform to develop a more error-free antibody test. $PMN.CA $ARFXF #covid19 #coronavirus #healthcare #stocks @ProMISinc
Image from Life Sciences Report (@SWLifeSciences)
1
ProMIS Neurosciences retweeted
NeurologyLive® (@neurology_live) profile picture
NeurologyLive®
@neurology_live19 Feb 2020
Sure, #aducanumab, if successful, will be good for Biogen and #Alzheimers disease, but what does its success mean for the drug development pipeline? @proMISinc CMO James Kupiec, MD discusses the impact on drug innovation. Read his editorial here: neurologylive.com/clinical-f…
3
1
4
ProMIS Neurosciences retweeted
NeurologyLive® (@neurology_live) profile picture
NeurologyLive®
@neurology_live20 Feb 2020
The chief medical officer of @ProMISinc comments on how #aducanumab will help propel innovation needed to drive the next generation of therapies for #Alzheimer disease. neurologylive.com/clinical-f…
1
1
3
ProMIS Neurosciences retweeted
John Vandermosten (@vanjohn10) profile picture
John Vandermosten
@vanjohn108 Jan 2020
$PMN issues Chairman statement. Highlights dose response, CTAD takeaways, no ρ between clinical benefit & plaque reduction & potential for treatment to become vectorized among other observations. promisneurosciences.com/wp-c…
1
2
That expert is our own Dr. Sharon Cohen!
Being Patient (@Being_Patient_) profile pictureBeing Patient@Being_Patient_5 Dec 2019
At #CTAD in San Diego this morning, #Biogen presented positive data on its #Alzheimers drug, saying #aducanumab worked in slowing progression of the disease. Experts called the results "exhilarating" and a "milestone achievement." Read more here: bit.ly/2DLOenn
Image from Being Patient (@Being_Patient_)
4
7
ProMIS Neurosciences retweeted
ProMIS Neurosciences (@ProMISinc) profile picture
ProMIS Neurosciences@ProMISinc9 Jul 2019
Replying to @SciReports
@SciReports publishes data showing therapeutic potential of PMN310 against the toxic oligomer form of amyloid beta, a root cause of #alzheimersdisease. Read at rdcu.be/bJeLB #alzheimers @RudyTanzi #StopAlz #EndAlz #EndAlzheimers
Image from ProMIS Neurosciences (@ProMISinc)
2
6
ProMIS Neurosciences retweeted
OTC Markets Group (@OTCMarkets) profile picture
OTC Markets Group@OTCMarkets3 Apr 2019
Listen in to our #latest #podcast w Cecilia Schoenbaum & Dr. Elliot Goldstein, CEO and President of @ProMISinc (OTCQB: $ARFXF) as they discuss how this biotech company is marrying physics & neurobiology to fight diseases including #Alzheimer’s ow.ly/uKKq50p1nuN
Image from OTC Markets Group (@OTCMarkets)
4
1
3
ProMIS Neurosciences retweeted
Stockhouse Publishing (@stockhouse) profile picture
Stockhouse Publishing
@stockhouse24 Nov 2016
#business Congratulations to the @ProMISinc $PMN team for being awarded @CIXCommunity #CIX16 "One of Canada's Most Innovative Companies"
Image from Stockhouse Publishing (@stockhouse)
4
1
10
ProMIS Neurosciences retweeted
Michael Bigger (@biggercapital) profile picture
Michael Bigger
@biggercapital11 Nov 2016
Who owns #Alzheimers multiple strains IP is valuable Evidence mounting @ProMISinc on right path nature.com/nrneurol/journal/… #endalz #biotech
3
6
ProMIS Neurosciences retweeted
Eden (@EdenRahim) profile picture
Eden
@EdenRahim26 Oct 2016
Can Alzheimers be stopped? Worth re-watching the always excellent Nova doc on #Alzheimers therapies in development youtu.be/XQioYgbhqO8
1
2
1
9
ProMIS Neurosciences retweeted
Hijack (@TheReclaimed202) profile picture
Hijack@TheReclaimed20218 Oct 2016
Replying to @MsCapitalMarket
@fireslayer96 @ProMISinc Very Accomplished man see link: bloomberg.com/research/stock…
3
1
ProMIS Neurosciences retweeted
EndAlz (@_EndAlz) profile picture
EndAlz@_EndAlz21 Sep 2016
It's #WorldAlzheimersDay ~ let's hope we're also one day closer to a cure. Let's #EndAlz for the next generation.
26
3
25
ProMIS Neurosciences retweeted
Michael Bigger (@biggercapital) profile picture
Michael Bigger
@biggercapital13 Sep 2016
"which is specificity for the prion like strains of Aβ with no binding to Aβ monomers or plaque" Improvement over Aducanumab? $PMN.T #ENDALZ
1
8
7
ProMIS Neurosciences retweeted
Scott (@scottfelsenthal) profile picture
Scott
@scottfelsenthal13 Sep 2016
Above all else, the news from $PMN.TO $PMN.CA this morning provides a glimmer of hope for all suffering from Alzheimer's. #ENDALZ
4
1
3
ProMIS Neurosciences retweeted
LundbeckUS (@LundbeckUS) profile picture
LundbeckUS
@LundbeckUS8 Sep 2016
#Alzheimers was identified more than 100 years ago, but still has no cure. Learn more: bit.ly/2cwBPVf
Image from LundbeckUS (@LundbeckUS)
6
77
7
76
ProMIS Neurosciences retweeted
Michael Bigger (@biggercapital) profile picture
Michael Bigger
@biggercapital3 Sep 2016
Replying to @scottfelsenthal @unusualstocks
@ProMISinc It took 9 yrs for $BIIB to figure out slight efficacy of Aducanumab due to its binding to one of the 6 prions
3
4
Load more